Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer

Human epidermal growth factor receptor 2 (HER2) overexpression has been reported in various human cancers. HER2-targeted therapies showed clinical responses in humans with HER2-positive tumors. The incidence of canine primary lung cancer (cPLC) is increasing, but there are no effective systemic ther...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Veterinary Medical Science 2020, Vol.82(6), pp.804-808
Hauptverfasser:	YOSHIMOTO, Sho, KATO, Daiki, KAMOTO, Satoshi, YAMAMOTO, Kie, TSUBOI, Masaya, SHINADA, Masahiro, IKEDA, Namiko, TANAKA, Yuiko, YOSHITAKE, Ryohei, ETO, Shotaro, SAEKI, Kohei, CHAMBERS, James, HASHIMOTO, Yuko, UCHIDA, Kazuyuki, NISHIMURA, Ryohei, NAKAGAWA, Takayuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Canis familiaris Carcinoma - genetics Carcinoma - metabolism Carcinoma - veterinary Dog Diseases - genetics Dog Diseases - metabolism Dogs Epidermal growth factor ErbB-2 protein Female Gene Expression Regulation, Neoplastic Immunohistochemistry - veterinary Lung cancer Lung Neoplasms - genetics Lung Neoplasms - metabolism Lung Neoplasms - veterinary Male Malignancy oncogene protein human epidermal growth factor receptor 2 Receptor, ErbB-2 - genetics Receptor, ErbB-2 - metabolism RNA, Messenger - metabolism Surgery Therapeutic applications Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!